GH Research PLC
GHRS · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.97 | -1.26 | 0.40 | -0.48 |
| FCF Yield | -1.19% | -1.34% | -2.88% | -3.54% |
| EV / EBITDA | -54.68 | -36.90 | -30.30 | -21.83 |
| Quality | ||||
| ROIC | -4.84% | -4.09% | -7.20% | -6.63% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.03 | 0.97 | 0.79 | 1.19 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -5.23% | 18.09% | 14.95% | -23.80% |
| Safety | ||||
| Net Debt / EBITDA | 27.53 | 22.78 | 11.49 | 7.54 |
| Interest Coverage | -1,633.78 | -71.53 | -72.31 | -69.73 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -5,653.42 | -4,316.54 | -3,356.20 |